SAT0065 Effects of Dmard Tapering on Treatment Costs in Rheumatoid Arthritis Patients- An Analysis from The Prospective Randomized Controlled Retro- Study

BackgroundAchieving remission is the most important treatment goal in patients with rheumatoid arthritis (RA). With the development and wider use of highly effective disease modifying anti-rheumatic drugs (DMARD) about half of RA patients reach a state of disease remission, raising the question abou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2016-06, Vol.75 (Suppl 2), p.688
Hauptverfasser: Hagen, M., Figueiredo, C., Cobra, J.F., Reiser, M., Haschka, J., Englbrecht, M., Hueber, A., Manger, B., Kleyer, A., Finzel, S., Tony, H.-P., Wendler, J., Kleinert, S., Schuch, F., Ronneberger, M., Feuchtenberger, M., Fleck, M., Manger, K., Ochs, W., Schmitt-Haendle, M., Lorenz, H.-M., Nuesslein, H., Alten, R., Henes, J.C., Krueger, K., Schett, G., Rech, J.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundAchieving remission is the most important treatment goal in patients with rheumatoid arthritis (RA). With the development and wider use of highly effective disease modifying anti-rheumatic drugs (DMARD) about half of RA patients reach a state of disease remission, raising the question about tapering or stopping anti-rheumatic treatment.ObjectivesTo assess the effect of a controlled DMARD tapering regimen on treatment costs and work productivity in RA patients in remissionMethods101 RA patients in sustained remission (DAS28
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2016-eular.4840